CLI reports new findings on consumer digital habits for contact lens
Research

CLI reports new findings on consumer digital habits for contact lens

Sneak peek of latest See Tomorrow initiative data unveils a need for more dual-wear conversations and patient education on contact lens removal.
New World Medical earns FDA clearance for VIA360 Surgical System
Products

New World Medical earns FDA clearance for VIA360 Surgical System

OVD delivery system is indicated to cut trabecular meshwork tissue during trabeculotomy procedures. 
DigitalOptometrics previews first-ever advanced autonomous slit lamp
Products

DigitalOptometrics previews first-ever advanced autonomous slit lamp

Debuting at Vision Expo East, the SlitLED captures ultra-high resolution, whole-cornea, and anterior segment images with detailed quality.
Optos launches next-gen UWF imaging system with SD-OCT
Products

Optos launches next-gen UWF imaging system with SD-OCT

The MonacoPro increases macular pathology identification by 29.4% when combined with the integrated 200° single-shot optomap imaging.
PlenOptika debuts mobile refraction platform for portable AR device
Products

PlenOptika debuts mobile refraction platform for portable AR device

The QuickSee Free Pro combines autorefaction and keratometry via wavefront aberrometry to deliver advanced refraction metrics.
Virtual Vision Health launches visual acuity testing for VR device
Products

Virtual Vision Health launches visual acuity testing for VR device

The Virtual Eye VR platform enables portable and cloud-based diagnostic exams in an all-in-one diagnostic solution.
Positive 52-week data supports 4DMT's wet AMD gene therapy
Pipeline

Positive 52-week data supports 4DMT's wet AMD gene therapy

PRISM trial extension cohort finds 4D-150 continues to be well tolerated after 3 years of follow-up; phase 3 program initiation to begin this year.
FDA approves updated label for IZERVAY to treat GA
Products

FDA approves updated label for IZERVAY to treat GA

Astellas’s avacincaptad pegol now has no limitation on its dosing duration, enabling longer-term administration for patients with GA secondary to AMD.
First-ever Corneal Health Summit kicks off in April
Events

First-ever Corneal Health Summit kicks off in April

A virtual one-day event for optometrists to feature industry-leading clinical experts, COPE-accredited sessions, and free CE credits.
Digital retinal imaging tool may detect dementia
Research

Digital retinal imaging tool may detect dementia

Researchers have created a retinal imaging database to develop AI-based software to detect neurodegenerative diseases during a routine eye exam. 
Researchers develop new OCT metric for detecting glaucoma
Pipeline

Researchers develop new OCT metric for detecting glaucoma

New pattern-based OCT metric uses a logistic regression model to more accurately detect glaucomatous damage—particularly in areas that conventional methods fail to identify.
Extended phase 3 study reports 3-year durability of EYLEA HD for wet AMD
Pipeline

Extended phase 3 study reports 3-year durability of EYLEA HD for wet AMD

Regeneron reports the majority of patients maintained visual and anatomic outcomes while achieving extended dosing regiments—including those switching from aflibercept 2 mg.
TECLens raises $9.3M in funding for non-invasive refractive tech
Business

TECLens raises $9.3M in funding for non-invasive refractive tech

The company's corneal CXL-based, non-incisional refractive correction procedure is designed to reshape the corneal for presbyopes and myopes.
New phase 3 data supports Eylea HD for macular edema following RVO
Pipeline

New phase 3 data supports Eylea HD for macular edema following RVO

Trial finds aflibercept 8 mg led to improved vision with extended dose intervals when compared to EYLEA 2 mg as Regeneron plans for a Q1 2025 sBLA submission.
CooperVision announces myopia management updates and plans
Business

CooperVision announces myopia management updates and plans

Company creates new position of Vice President, Myopia Management & Cornea Care and previews clinical investigation plans.
Researchers identify link between e-cigs and uveitis
Research

Researchers identify link between e-cigs and uveitis

Investigation finds an increased risk of uveitis in e-cigarette users.
Clearside Biomedical reports phase 2b analyses of CLS-AX for wet AMD
Pipeline

Clearside Biomedical reports phase 2b analyses of CLS-AX for wet AMD

Data from two sub-groups to determine design of two phase 3 clinical trials evaluating the use of axitinb injectable suspension with the SCS Microinjector.
EyePoint releases positive 6-month data from phase 2 DME trial
Pipeline

EyePoint releases positive 6-month data from phase 2 DME trial

DURAVYU (vorolanib intravitreal insert) 2.7 mg dose demonstrates early and sustained BCVA improvements plus extended time to first supplemental injection versus aflibercept.
Iantrek names former Trukera Medical leader as new CEO
Business

Iantrek names former Trukera Medical leader as new CEO

Adam Szaronos joins the biotechnology company as it plans a full commercial launch of two surgical glaucoma devices later this year.
 New research supports efficacy of AI in home OCT monitoring
Research

New research supports efficacy of AI in home OCT monitoring

Cross-sectional study results led to the first-ever clearance of an AI algorithm applied to OCT images: Notal Vision’s SCANLY Home OCT.